Sr. V.P. Nash Elisabeth G. sold 42,400 shares of SCI at $76.32; stock now $77.13, down 4.3% in 30 days.
Nash Elisabeth G. sold 42.4K shares (27.8% of her pre-transaction holdings of 152.4K shares) at $76.32 on 2025-12-04, reducing her position to 110.0K shares. The sale occurred near the upper-middle range of the 52-week band ($73.58–$87.95) and ahead of a subsequent decline—the stock has fallen 4.3% in the 30 days following the transaction. Across her prior three trades at SCI, her timing has been mixed: one prior sale on 2024-11-18 was followed by a 90d decline of -10.5%, while two earlier 2023 sales preceded 90d gains of +11.5% and +11.7%, yielding a 33.33% success rate at well-timed exits on this ticker. SCI is trading at a modest P/E of 20.24 with solid fundamentals (revenue $1.1B, net income $117.5M, 2.1% annual growth), but the recent post-transaction price decline aligns with one favorable precedent in her SCI-specific history.
SCI Sr. V.P. Elizabeth Nash sold 56,100 shares at $86.13 for $4.8M on 2024-11-18, reducing holdings 33.9%
Nash Elisabeth G. executed a substantial sale of 56,100 shares (33.9% of her pre-transaction holdings), realizing approximately $4.8M at $86.13 per share. Her prior two sales at SCI in late November 2023 both posted positive 90-day returns of 18.0% and 17.0% respectively, indicating the stock rose after those sales—a pattern inconsistent with well-timed sales. The current price of $85.42 sits near the 52-week high of $87.00, and the stock has appreciated 12.3% over the past 30 days and 12.1% over 90 days. Fundamentals show flat annual revenue growth (-0.2%) and a relatively elevated P/E of 24.48, warranting attention to whether her significant reduction in direct exposure signals concern about valuation or reflects routine portfolio rebalancing unrelated to business outlook.
